AE monitoring system. by Zhenhua Wang (426041)

“…At the same temperature, shear strength increases at a rate of 5.6 MPa/°C with increasing confining pressure; as freezing temperature decreases, the shear strength increases at 0.34 MPa/°C, and cohesion increases at 0.6 MPa/°C. …”

MTS-370.25 fatigue resting system. by Zhenhua Wang (426041)

“…At the same temperature, shear strength increases at a rate of 5.6 MPa/°C with increasing confining pressure; as freezing temperature decreases, the shear strength increases at 0.34 MPa/°C, and cohesion increases at 0.6 MPa/°C. …”

Schematic diagram of the AE testing system. by Zhenhua Wang (426041)

“…At the same temperature, shear strength increases at a rate of 5.6 MPa/°C with increasing confining pressure; as freezing temperature decreases, the shear strength increases at 0.34 MPa/°C, and cohesion increases at 0.6 MPa/°C. …”

Strain at different positions of the sample. by Zhenhua Wang (426041)

“…At the same temperature, shear strength increases at a rate of 5.6 MPa/°C with increasing confining pressure; as freezing temperature decreases, the shear strength increases at 0.34 MPa/°C, and cohesion increases at 0.6 MPa/°C. …”

KYNA and zaprinast decrease the [Ca²⁺]i plateau phase following an IP3-mediated stimulus in mouse cortical astrocytes. by Rolando Berlinguer-Palmini (491113)

“…<p><b>A</b>) A typical example of KYNA and zaprinast-induced decrease in somatic fluo-3 fluorescence time course measured in three different astrocytes in cultures: control (<i>upper panels</i>), in the presence of 10 μM KYNA (<i>middle panels</i>) or zaprinast 1 µM (<i>lower panels</i>). …”

Extracellular vesicles isolated from patients undergoing remote ischemic preconditioning decrease hypoxia-evoked apoptosis of cardiomyoblasts after isoflurane but not propofol expo... by Frederik Abel (8452101)

“…Hypoxia increased apoptosis of H9c2 cells (hypoxia: 8.4%±0.6; normoxia: 2.5%±0.1; p<0.0001). RIPC-EVs decreased H9c2 cell apoptosis compared to control (apoptotic ratio: 0.83; p = 0.0429) while Sham-EVs showed no protection (apoptotic ratio: 0.97). …”

Synthesis of Binucleating Macrocycles and Their Nickel(II) Hydroxo- and Cyano-Bridged Complexes with Divalent Ions: Anatomical Variation of Ligand Features by Xiaofeng Zhang (172446)

“…Syntheses of macrocycle <b>5</b> with a 7-Me-[12]­aneSN₃ and macrocycle <b>6</b> with a 1,8-Me₂-[14]­aneN₄ M^II binding site are described together with hydoxo-bridged Ni/Cu and cyano-bridged Ni/Fe complexes. …”

Clinical evolution at 30 days in the different treatment groups. by Ismael Francisco Aomar-Millán (14838595)

Subjects:

SaFi, laboratory, radiology, vaccine status, and inpatient treatment data. by Ismael Francisco Aomar-Millán (14838595)

Subjects:

Adverse pregnancy outcomes recorded among study participants. by Seth Amponsah-Tabi (13949142)

Subjects:

Probability of medical discharge at 60 days in the different treatment groups. by Ismael Francisco Aomar-Millán (14838595)

Subjects:

Quality of Antenatal care and adverse maternal and fetal outcomes. by Seth Amponsah-Tabi (13949142)

Subjects:

Distribution of different levels of quality of antenatal care provided to study participants. by Seth Amponsah-Tabi (13949142)

Subjects:

Sociodemographic and reproductive factors associated with good quality antenatal care. by Seth Amponsah-Tabi (13949142)

Subjects:

Sociodemographic and reproductive characteristics of the study participants. by Seth Amponsah-Tabi (13949142)

Subjects:

Comorbidities and severity scales at admission for the different treatment groups. by Ismael Francisco Aomar-Millán (14838595)

Subjects:

S1 Data - by Seth Amponsah-Tabi (13949142)

Subjects:

Probability of remaining as an inpatient at 30 days in the different treatment groups. by Ismael Francisco Aomar-Millán (14838595)

Subjects:

Probability of medical discharge at 30 days in the different treatment groups. by Ismael Francisco Aomar-Millán (14838595)

Subjects:

Probability of remaining as an inpatient at 60 days in the different treatment groups. by Ismael Francisco Aomar-Millán (14838595)

Subjects: